The FINANCIAL — GlaxoSmithKline and Save the Children launched a $1 million Healthcare Innovation Award to identify and reward innovations in healthcare which have proven successful in reducing child deaths in developing countries, according to GlaxoSmithKline, a global healthcare company.
The award will provide a platform for winning organisations to showcase their innovations and share information to enable others with an interest in improving healthcare to adapt and replicate successful interventions and create more positive change for children in their own country and beyond, according to GlaxoSmithKline.
“Often the best solutions to a particular challenge come from those living and working closest to it. We recognise this and we are committed to supporting those working in the world’s poorest countries to improve health outcomes. This award will identify the most effective ideas being put into practice in developing countries and, by providing much needed funding, will enable these innovations to be scaled-up to reduce childhood deaths and will inspire others in the process,” said Sir Andrew Witty, CEO of GSK.
“We believe that we can be the generation to stop children dying from preventable causes – but this can only happen by working in partnership and finding new, innovative ways to get to the hardest to reach children. Through the GSK and Save the Children Healthcare Innovation Award, we can identify and support new and exciting examples of innovation from emerging and developing countries, in order to save more children’s lives,” said Justin Forsyth, Chief Executive, Save the Children UK.
Discussion about this post